Under infusionen blev der rapporteret om arytmier af grad 3 eller 4 (herunder ventrikulær og supraventrikulær takykardi) og
During maintenance treatment, the incidence of grade 3/ 4 cardiac disorders was comparable between patients treated with MabThera and observation.